The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
hydra biosciences | 229 |
cubist pharmaceuticals | 10 |
boehringer ingelheim international | 5 |
cubist pharm | 1 |
merck & company | 1 |
hydra biosciences | 8 |
hydra biosciences | 23 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
substituted xanthines and methods of use thereof | 58 | 2013 |
methods and compositions for treating disorders | 28 | 2007 |
methods and compositions for treating pain | 27 | 2005 |
inhibiting transient receptor potential ion channel trpa1 | 14 | 2011 |
substituted xanthines and methods of use thereof | 12 | 2013 |
compounds and compositions for treating chemical warfare agent-induced injuries | 11 | 2008 |
inhibiting the transient receptor potential a1 ion channel | 11 | 2014 |
compounds for modulating trpv3 function | 9 | 2005 |
compositions useful for treating disorders related to trpa1 | 8 | 2008 |
methods and compositions for treating anxiety | 8 | 2008 |